Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Peter J., Pommerville"'
Autor:
Michael Chancellor, Chris R. Chapple, Giulio Del Popolo, Denise Globe, Wayne Lam, Peter J. Pommerville, Patrick J. Shenot, David Sussman
Publikováno v:
PM&R. 3
Autor:
Craig F, Donatucci, Gerald B, Brock, Evan R, Goldfischer, Peter J, Pommerville, Albert, Elion-Mboussa, Jay D, Kissel, Lars, Viktrup
Publikováno v:
BJU international. 107(7)
• To evaluate the 1-year safety of 5 mg of tadalafil once daily in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH-LUTS); efficacy measures were included to evaluate the maintenance of efficacy after an addition
Autor:
Peter J, Pommerville, Johan G, de Boer
Publikováno v:
The Canadian journal of urology. 17(2)
Analogues of the gonadotropin releasing hormone (GnRH) inhibit the hypothalamic-pituitary-gonadal axis. This has provided treatment modalities for advanced and metastatic prostate cancer. The latest group of analogues, the GnRH antagonists, make prom
Publikováno v:
The Canadian journal of urology. 16(2)
Intravesical Bacillus Calmette-Guérin (BCG) is widely used as an adjuvant therapy in the treatment of superficial bladder cancer. BCG is administered as a live, attenuated form of Mycobacterium bovis, and acts as an immunomodulary agent to delay tum
Autor:
Marc, Gittelman, Peter J, Pommerville, Bo-Eric, Persson, Jens-Kristian, Jensen, Tine Kold, Olesen, Norman, Zinner
Publikováno v:
The Journal of urology. 180(5)
Degarelix is a gonadotropin-releasing hormone receptor antagonist (blocker) with rapid onset of action suppressing gonadotropins, testosterone and prostate specific antigen in prostate cancer. In the present open label, randomized study in North Amer
Autor:
Andrzej Borkowski, Gerald L. Andriole, Harin Padma-Nathan, Charles B. Herring, Craig F. Donatucci, Vincenzo Gentile, A. Leriche, Eric Wespes, Jack Barkin, Randall P. Abele, Donald Bergner, H. Asscheman, Stacy Childs, William B. Monnig, Jon Lee Peterson, William A. Leitner, Arnold Melman, Fabrizio Menchini Fabris, R. F. Kropman, Enrico Pisani, Jack Lubensky, David Ralph, Stephen Auerbach, Jeoffrey Deeths, Nizamuddin Maruf, Fred Govier, Robert Feldman, Vincenzo Bonifacio, Roger De Bruyne, James E. Gottesman, F. Francesca, William Iii Fitch, Selwyn Cohen, Roger Fincher, Francis Duyck, Phillip Kell, Alan Lau, Björn Lundquist, Vincenzo Mirone, Emanuele Belgrano, Kazimierz Krajka, Evan R. Goldfischer, Francesco Paolo Selvaggi, Wilbert Dinsmore, Gaetano Frajese, Joel M. Kaufman, Pamela I. Ellsworth, V. Gary Price, Joel Lilly, Peter J. Pommerville, Geoffrey Hackett, M. Speakman, Wayne J.G. Hellstrom, Michael B. Greenspan, Pierre Bondil, Larry I. Gilderman, Emmanuel Blanc, Overlæge Peter Lyngdorf, Arcangelo Pagliarulo, Howard B. Epstein, Thierry Lebret, Thomas Gerstenberg, Keith Matthews, John N. Krieger, Peter Ekman, François Giuliano, Ian Eardley, Benny Verheyden, Roger Kirby, Allan B. Patrick, Georges Declercq, Jenelle E. Foote, Christer Dahlstrand, Eric J.H. Meuleman, Craig Niederberger, Mostafa M. Elhilali, Olivier Lan, Harold A. Fuselier, Andrew McCullough, Richard Casey, Winston Barzell, Beatrice Cuzin, Marc Gittelman, Kevin T. McVary, Louis Fields, Pierre Costa, Kanaiyalal Desai, Dirk Vanderscheuren, Robert J. Krane, Gary S. Karlin, Martin Homering, Francesco Montorsi, Giorgio Carmignani, Guglielmo Breda, Thom Segerson, Jacques Buvat, Robert Porto, David O. Cook, Jeffrey Frankel
Vardenafil (Levitra) is a potent and selective phosphodiesterase 5 (PDE5) inhibitor used in the management of erectile dysfunction (ED). This retrospective subgroup analysis assessed the effectiveness of vardenafil treatment in men with ED of differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e89ba4cd8369d684bf7e2dfb20eb1a0
http://hdl.handle.net/11588/486018
http://hdl.handle.net/11588/486018
Autor:
Peter J Pommerville
Publikováno v:
Journal of Sexual & Reproductive Medicine.
Vardenafil is a new phosphodiesterase 5 inhibitor designed specifically to be an effective and safe oral treatment for erectile dysfunction (ED). The present review provides a broad overview, with emphasis placed on results from key studies that will
Publikováno v:
The Canadian journal of urology. 6(3)
INTRODUCTION: High Intensity Focused Ultrasound (HIFU) ablates benign prostatic tissue in a minimally invasive manner with low morbidity. The safety and effectiveness of treating of benign prostatic hypertrophy (BPH) with HIFU using 3 different proto
Autor:
Peter J Pommerville, Blair Egerdie, Samuel Denmeade, Rosemina Merchant, Tom Buckley, Ralph Abi-Habib
Publikováno v:
Journal of Urology. 179:673-674